VULVAR NEOPLASMS
Clinical trials for VULVAR NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new VULVAR NEOPLASMS trials appear
Sign up with your email to follow new studies for VULVAR NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: VULVAR NEOPLASMS
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
Blood test and patient survey aim to catch vulva cancer relapse early
Knowledge-focused Recruiting nowThis study looks at new ways to detect if vulva cancer has come back after treatment. Researchers will ask 295 women to fill out surveys every four months and give blood samples to look for cancer DNA. They will compare results with a group of 1000 women treated in the past. The …
Matched conditions: VULVAR NEOPLASMS
Phase: NA • Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated May 26, 2026 04:42 UTC